A detailed history of Nordea Investment Management Ab transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Nordea Investment Management Ab holds 537,456 shares of DGX stock, worth $73.7 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
537,456
Previous 594,304 9.57%
Holding current value
$73.7 Million
Previous $81.3 Million 9.43%
% of portfolio
0.09%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$137.09 - $137.09 $7.79 Million - $7.79 Million
-56,848 Reduced 9.57%
537,456 $73.7 Million
Q2 2024

Aug 08, 2024

SELL
$125.91 - $144.34 $274,231 - $314,372
-2,178 Reduced 0.37%
594,304 $81.3 Million
Q1 2024

May 02, 2024

SELL
$123.78 - $142.11 $2.11 Million - $2.42 Million
-17,053 Reduced 2.78%
596,482 $79.4 Million
Q4 2023

Jan 10, 2024

SELL
$120.62 - $141.12 $46.5 Million - $54.4 Million
-385,484 Reduced 38.59%
613,535 $84.6 Million
Q3 2023

Nov 13, 2023

SELL
$121.86 - $144.92 $3.29 Million - $3.91 Million
-27,008 Reduced 2.63%
999,019 $122 Million
Q2 2023

Jul 07, 2023

BUY
$130.56 - $146.84 $4.19 Million - $4.71 Million
32,105 Added 3.23%
1,026,027 $144 Million
Q1 2023

Apr 19, 2023

BUY
$131.53 - $155.76 $2.34 Million - $2.77 Million
17,760 Added 1.82%
993,922 $141 Million
Q4 2022

Feb 08, 2023

BUY
$123.31 - $157.26 $9.08 Million - $11.6 Million
73,655 Added 8.16%
976,162 $153 Million
Q3 2022

Oct 19, 2022

BUY
$121.77 - $141.1 $1.41 Million - $1.64 Million
11,594 Added 1.3%
902,507 $113 Million
Q2 2022

Aug 09, 2022

BUY
$127.07 - $145.39 $25.7 Million - $29.4 Million
202,318 Added 29.38%
890,913 $121 Million
Q1 2022

Apr 11, 2022

BUY
$129.09 - $164.35 $9.03 Million - $11.5 Million
69,940 Added 11.31%
688,595 $95.7 Million
Q4 2021

Jan 20, 2022

BUY
$140.36 - $173.01 $5.92 Million - $7.29 Million
42,155 Added 7.31%
618,655 $107 Million
Q3 2021

Nov 01, 2021

SELL
$132.95 - $158.0 $76.6 Million - $91.1 Million
-576,500 Reduced 50.0%
576,500 $85.7 Million
Q3 2021

Nov 01, 2021

SELL
$132.95 - $158.0 $187 Million - $222 Million
-1,406,189 Reduced 54.95%
1,153,000 $168 Million
Q2 2021

Jul 16, 2021

BUY
$126.66 - $141.48 $25.3 Million - $28.2 Million
199,575 Added 8.46%
2,559,189 $338 Million
Q1 2021

May 17, 2021

BUY
$114.63 - $133.34 $72.1 Million - $83.8 Million
628,637 Added 36.32%
2,359,614 $301 Million
Q4 2020

Feb 12, 2021

BUY
$112.7 - $128.05 $32.3 Million - $36.7 Million
286,486 Added 19.83%
1,730,977 $206 Million
Q3 2020

Nov 09, 2020

BUY
$107.05 - $130.01 $88.4 Million - $107 Million
825,685 Added 133.43%
1,444,491 $166 Million
Q2 2020

Aug 13, 2020

BUY
$73.34 - $122.61 $33.3 Million - $55.7 Million
454,048 Added 275.58%
618,806 $70.5 Million
Q1 2020

May 15, 2020

SELL
$75.14 - $115.68 $23,143 - $35,629
-308 Reduced 0.19%
164,758 $13.2 Million
Q4 2019

Feb 11, 2020

BUY
$100.29 - $107.99 $1.09 Million - $1.18 Million
10,885 Added 7.06%
165,066 $17.6 Million
Q3 2019

Nov 13, 2019

SELL
$97.85 - $107.42 $259,693 - $285,092
-2,654 Reduced 1.69%
154,181 $16.4 Million
Q2 2019

Aug 14, 2019

BUY
$85.18 - $101.94 $340,294 - $407,250
3,995 Added 2.61%
156,835 $16 Million
Q1 2019

May 20, 2019

BUY
$80.68 - $89.92 $1.38 Million - $1.54 Million
17,107 Added 12.6%
152,840 $13.7 Million
Q4 2018

Feb 14, 2019

BUY
$79.75 - $108.38 $10.2 Million - $13.9 Million
127,977 Added 1650.04%
135,733 $11.3 Million
Q3 2018

Nov 14, 2018

BUY
$105.42 - $114.99 $52,499 - $57,265
498 Added 6.86%
7,756 $837,000
Q1 2018

May 14, 2018

SELL
$96.42 - $107.88 $277,496 - $310,478
-2,878 Reduced 28.39%
7,258 $728,000
Q4 2017

Feb 12, 2018

SELL
$90.86 - $100.24 $11,630 - $12,830
-128 Reduced 1.25%
10,136 $998,000
Q3 2017

Nov 09, 2017

BUY
$91.96 - $108.35 $943,877 - $1.11 Million
10,264
10,264 $961,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.